CME 2026 ASLMS 45th Annual Conference Recordings - Seeing Red - All Things Vascular
The course was recorded on May 8, 2026, at the ASLMS Annual Conference.
Course Description: Vascular lasers can target red lesions, both vascular and non-vascular. This session will feature use of lasers for common vascular lesions as well as use of vascular lasers for other disorders.
COURSE DIRECTORS: Roy G. Geronemus, MD – Dermatologist, Director, Roy G. Geronemus MD; Kristen M. Kelly, MD – Chair of Dermatology, University of California Irvine
FACULTY PANELISTS: Kristen M. Kelly, MD – Chair of Dermatology, University of California Irvine; Lisa M. Arkin, MD – Associate Professor, University of Wisconsin School of Medicine and Public Health, Madison, WI; Paul M. Friedman, MD;
Grewal, MD, FAAD; Jessica G. Labadie, MD; Merete Haedersdal, MD, PhD, DMSc
LEARNING OBJECTIVES:
At the end of the activity, learners should be able to:
- Understand how devices work for treatment of vascular conditions.
- Apply the most current information and advanced techniques for treatment of vascular conditions
TARGET AUDIENCE:
This activity is intended for an audience of physicians and other healthcare professionals interested in the use of lasers, light, energy-based devices, and related technologies across various specialties.
PRESENTATIONS:
Intro to Vascular Lesion Treatment | Kristen M. Kelly, MD – Chair of Dermatology, University of California Irvine
Vascular Tumors and Malformations | Lisa M. Arkin, MD – Associate Professor, University of Wisconsin School of Medicine and Public Health, Madison, WI
Rosacea and Telangiectases | Paul M. Friedman, MD
Pediatric Vascular Laser Treatments | Roy G. Geronemus, MD – Dermatologist, Director, Roy G. Geronemus MD
DISCLOSURES:
The American Society for Laser Medicine and Surgery (ASLMS) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ASLMS are required to disclose all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by ASLMS in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ASLMS to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ASLMS.
All planners and faculty for this educational activity, except for those listed below, have no financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
- Kristen M. Kelly, MD discloses the following financial relationships: Bausch Health: Investigator; MundiPharma, Allergan, Syneron Candela, Light Sciences Oncology, Novartis, Sciton, and ThermiRF: Consulting Fees (e.g., advisory boards) (Ongoing), Honoraria (Ongoing)
- Lisa M. Arkin, MD discloses the following financial relationships: AMGEN: Contracted Research (Principal Investigators must provide information, even if received by the institution); Eli Lily: Consulting Fees (e.g., advisory boards); Eli Lily: Contracted Research (Principal Investigators must provide information, even if received by the institution); Merck: Consulting Fees (e.g., advisory boards)
- Paul M. Friedman, MD discloses the following financial relationships: Acclaro Corp: Consulting Fees (e.g., advisory boards), Contracted Research (Principal Investigators must provide information, even if received by the institution), Stock Options Holder; Allergan, Inc: Consulting Fees (e.g., advisory boards); Bausch Health: Contracted Research (Principal Investigators must provide information, even if received by the institution); Candela: Consulting Fees (e.g., advisory boards), Contracted Research (Principal Investigators must provide information, even if received by the institution), Speakers' Bureau; Solta Medical: Consulting Fees (e.g., advisory boards), Speakers' Bureau; Veradermics, Inc.: Consulting Fees (e.g., advisory boards)
- Roy G. Geronemus, MD discloses the following financial relationships: Accure: Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed) (Ongoing); Allergan / Abbvie: Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Avava: Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Candela: Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Cytrellis: Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Lutronic/Cynosure: Consulting Fees (e.g., advisory boards) (), Contracted Research (Principal Investigators must provide information, even if received by the institution) (); New York Stem Cell Foundation: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Novoxel: Contracted Research (Principal Investigators must provide information, even if received by the institution) (); Sofwave: Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Solta: Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)
- ASLMS staff planners and reviewers have no relevant financial relationships to disclose.
ACCME Accreditation Statement:
The American Society for Laser Medicine and Surgery, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement:
The American Society for Laser Medicine and Surgery, Inc. designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credits:
This enduring material is eligible for 2.0 credits if you are a Registered Nurse. These credits are provided with co-sponsorship with the Laser Training Institute division of Professional Medical Education Association.
Instructions for Learners to Receive Credit:
To receive a Certificate of Credit or a Certificate of Participation for this On-Demand (2026) course, registered attendees must submit a completed electronic CME/CE evaluation by the course expiration date (11/30/26).
This course should take approximately 1.5 hours to complete.
REFUND/CANCELLATION POLICY:
For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283.
- Refund requests will only be considered if made within 14 days of purchase.
- Refunds will only be considered if you have not yet started the course (no content viewed).
- Refunds are not available for missed live activities.
- Contact information@aslms.org to request a refund.
CONTACT INFORMATION:
For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283.
DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
DISCLOSURE OF OFF-LABEL USE:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Society for Laser Medicine & Surgery does not recommend the use of any agent outside of the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
Roy Geronemus, MD (Moderator)
Medical Director
Laser & Skin Surgery Center of New York
Roy G. Geronemus, M.D., Director of the Laser & Skin Surgery Center of New York®, graduated from Harvard University and pursued his medical education at the University of Miami School of Medicine.
He trained in dermatology at the New York University Medical Center where he was the chief resident and subsequently underwent a fellowship training in Mohs Micrographic Surgery and Cutaneous Oncology. He is a Clinical Professor of Dermatology at New York University Medical Center where he founded its laser program and served nine years as chief of dermatologic and laser surgery. He is past president of the American Society for Dermatologic Surgery, American Society for Laser Medicine & Surgery, New York Dermatological Society, Dermatologic Society of Greater New York and Association of Academic Dermatologic Surgeons. Dr. Geronemus is the Chairman of the Board of the New York Stem Cell Foundation.
The American Society for Laser Medicine and Surgery has awarded Dr. Geronemus with the Ellet Drake award for outstanding contributions to laser medicine and the Leon Goldman award for excellence in clinical laser research. The American Society for Dermatologic Surgery (ASDS) has awarded him the Samuel J. Stegman award for distinguished service and the Vic Narurkar, M.D., Innovations in Aesthetic Dermatology Lectureship Award.
The University of Miami School of Medicine has elected him into their alumni Hall of Fame. He has received the Physician of the Year honor from the Vascular Birthmark Foundation and was also awarded their Humanitarian Award in 2014.
Dr. Geronemus has published over 400 medical articles, chapters and books. He has been involved with the development of multiple new laser systems and therapeutic techniques, which are now commonly used throughout the world.
Kristen Kelly, MD (Moderator)
Professor
University of California, Irvine
Dr. Kristen M. Kelly is a board certified dermatologist and Professor and Chair of the Department of Dermatology at the University of California (UC), Irvine. She attended UC Los Angeles as an undergraduate and medical student. She completed an internal medicine internship and then a dermatology residency at UC Irvine. After residency, Dr. Kelly was a fellow in photomedicine and biomedical optics at the Beckman Laser Institute and then obtained an academic appointment in the departments of dermatology and surgery at UC Irvine. In 2021, she started in her position as the first female Chair for the Department of Dermatology at UC Irvine. Her research has helped to optimize cutaneous vascular lesion treatment, evaluate cutaneous angiogenesis, and develop and evaluate novel dermatologic light based imaging and therapeutic options. She works with a number of patient advocacy groups including The Sturge Weber Foundation and The Vascular Birthmark Foundation. She has given over 300 lectures at local, national and international conferences and events and has authored over 140 scientific papers and 19 book chapters. Dr. Kelly is a fellow of the American Academy of Dermatology and her research has been funded by the American Society for Laser Medicine and Surgery, Sturge Weber Foundation, Dermatology Foundation and National Institutes of Health.
Lisa Arkin, MD
Associate Professor of Dermatology
University of Wisconsin School of Medicine and Public Health
Dr. Lisa Arkin is an Associate Professor of Dermatology, Director of Pediatric Dermatology, and a Co-Director of the Birthmarks and Vascular Anomalies Center (BVAC) at the University of Wisconsin School of Medicine and Public Health. She studied American History at Brown University and graduated from the University of Pennsylvania School of Medicine. She completed her residency in dermatology at Northwestern University Feinberg School of Medicine, and a fellowship in pediatric dermatology at the Children’s Hospital of Philadelphia/University of Pennsylvania.
She is passionate about laser treamtent for vascular anomalies. In this realm, she has fostered research and clinical collaborations between laser surgeons and pediatric dermatologists, driven by the belief that synergy between fields is critical to understanding natural history, defining best practices, and improving outcomes. Her research primarily focuses on precision-based approaches to facial port wine birthmarks leveraging novel imaging, and investigation of potential downtream medical targets for therapy.
Paul Friedman, MD
Board-Certified Dermatologist
Dermatology & Laser Surgery Center, Houston, Texas; McGovern Medical School, University of Texas Health Science Center, Houston, Texas
Paul M. Friedman, MD, board-certified by the American Board of Dermatology, is the director of Dermatology & Laser Surgery Center of Houston, Texas, and also practices at the Laser & Skin Surgery Center of New York. He was educated in dermatology at the New York University School of Medicine where he served as chief resident and was twice awarded the prestigious Husik Prize for his research in dermatologic surgery. He completed a one-year fellowship in dermatologic laser surgery and Mohs micrographic surgery & cutaneous oncology at the Laser & Skin Surgery Center of New York and was the recipient of the Young Investigator's Writing Competition Award of the American Society for Dermatologic Surgery (ASDS). Dr. Friedman is a clinical assistant professor at the University of Texas Medical School, department of dermatology, and a clinical assistant professor of dermatology at the Weill Cornell Medical College, Houston Methodist Hospital. He is also on staff at Texas Children's Hospital and Memorial-Hermann Hospital-Texas Medical Center. Dr. Friedman is a fellowship director for the ASDS-accredited cosmetic dermatologic surgery fellowship training program and also serves as faculty for the Procedural Dermatology Fellowship at MD Anderson Cancer Center.
Dr. Friedman has been a featured speaker of ASDS, the American Academy of Dermatology, the American Society for Laser Medicine and Surgery (ASLMS), and other national and international audiences. He recently served as past President of ASLMS and was awarded the prestigious Leon Goldman Memorial Award at the 2019 ASLMS Annual Conference. Dr. Friedman has published over 100 medical articles and book chapters and co-authored the book Beautiful Skin Revealed: The Ultimate Guide to Better Skin. He is co-Editor of the textbook Lasers and Light Source Treatment For The Skin and serves on the Editorial Board of the journal Dermatologic Surgery. He has been featured in numerous national media outlets and is a frequent guest on Doctor Radio’s Dermatology Show. Dr. Friedman has been recognized as a leading physician and researcher in the field and has also been involved in the development of several new laser systems and therapeutic techniques now commonly used throughout the world.
Key:
Complete
Next
Failed
Available
Locked